Gangliosides do not elicit experimental autoimmune encephalomyelitis in Lewis rats and SJL mice

Journal of Neuroimmunology

Volumn 84, Issue 1, 1998, Pages 24-29

  Sáez Torres, Irene ^a   Díaz Villoslada, Pablo ^a   Martínez Cáceres, Eva ^a   Ferrer, Isidro ^b   Montalban, Xavier ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Experimental autoimmune encephalomyelitis; Gangliosides; Lewis rat; Methylated bovine serum albumin; SJL mouse

Indexed keywords

BOVINE SERUM ALBUMIN; FREUND ADJUVANT; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD2; PERTUSSIS VACCINE; UNCLASSIFIED DRUG; VAXICOQ;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN PROTECTION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; IMMUNIZATION; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIBODIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GANGLIOSIDES; IMMUNIZATION; MICE; RATS; RATS, INBRED LEW; SERUM ALBUMIN, BOVINE; T-LYMPHOCYTES;

EID: 0032054055     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00213-0     Document Type: Article

References (23)

1. Acarin N., Rio J., Fernandez A.L., Tintore M., Duran I., Galan I., Montalban X. Different antiganglioside antibody pattern between relapsing-remitting and progressive multiple sclerosis. Acta Neurol. Scand. 93:1996;99-103.
2. Arnon R., Crisp E., Kelley R., Ellison G.W., Myers L.W., Tourtellotte W.W. Antiganglioside antibodies in multiple sclerosis. J. Neurol. Sci. 46:1980;179-186.
3. Brosnan C.F., Traugott U., Raine C.S. Analysis of humoral and cellular events and the role of lipids haptens during CNS demyelination. Acta Neuropathol. 9:1983;59-70.
4. Cohen O., Sela B.A., Schwartz M., Eshhar N., Cohen I.R. Multiple sclerosis-like disease induced in rabbits by immunization with brain gangliosides. Isr. J. Med. Sci. 17:1981;711-714.
5. Endo T., Scott D.D., Stewart S.S., Kundu S.K., Marcus D.M. Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE. J. Immunol. 132:1984;1793-1797.
6. Gautam A.M. Self and non-self peptides treat autoimmune encephalomyelitis: T-cell anergy or competition for major histocompatibility complex class II binding? Eur. J. Immunol. 25(7):1995;2059-2063.
7. Goverman J., Brabb T. Rodent models of experimental allergic encephalomyelitis applied to the study of multiple sclerosis. Lab. Animal Sci. 46(5):1996;482-492.
8. Hosein Z.Z., Gilbert J.J., Strejan G.H. The role of myelin lipids in experimental allergic encephalomyelitis. Part 2. Influence on disease production by encephalitogenic doses of myelin basic protein. J. Neuroimmunol. 10:1986;219-233.
9. Ilyas A.A., Willison H.J., Quarles R.H., Jungalwala F.B., Cornblath D.R., Trapp B.D., Griffin D.E., Griffin J.W., McKhann G.M. Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann. Neurol. 23(5):1988;440-447.
10. Inoue A., Koh C.S., Yanagisawa N., Taketomi T., Ishihara Y. Suppression of Theiler's murine encephalomyelitis virus induced demyelinating disease by administration of gangliosides. J. Neuroimmunol. 64:1996;45-53.
11. Jackson K.M., Yates A.J., Orosz C.G., Whitacre C.C. Gangliosides suppress the proliferation of autoreactive cells in experimental allergic encephalomyelitis: Ganglioside effects on IL-2 activity. Cell. Immunol. 104:1987;169-181.
12. Konat G., Offner H., Lev-Ram V., Cohen O., Schwartz M., Cohen I.R., Sela B.A. Abnormalities in brain myelin of rabbits with experimental autoimmune multiple sclerosis-like disease induced by immunization to gangliosides. Acta Neurol. Scand. 66:1982;568-574.
13. Kusunoki S., Yu R.K., Kim J.H. Induction of experimental allergic encephalomyelitis in guinea pigs using myelin basic protein and myelin glycolipids. J. Neuroimmunol. 18:1988;303-314.
14. Ledeen R.W., Oderfeld-Nowak B., Brosnan C.F., Cervone A. Gangliosides offer partial protection in experimental allergic neuritis. Ann. Neurol. 27:1990;S69-S74.
15. Mullin B.R., Patrick D.H., Poore C.M.B., Rupp B.H., Smith M.T. Prevention of experimental allergic encephalomyelitis by gangliosides GM4. A follow-up study. J. Neurol. Sci. 73(1):1986;55-60.
16. Offner H., Vandenbark A.A. Gangliosides inhibit phenotypic and functional properties of an encephalitogenic T-helper lymphocyte line. Cell. Immunol. 95:1985;84-94.
17. Pestronk A., Cornblath D.R., Ilyas A.A., Baba H., Quarles R.H., Griffin J.W., Alderson K., Adams R.N. A treatable multifocal neuropathy with antibodies to GM gangliosides. Ann. Neurol. 24(1):1988;73-78.
18. Ponzin D., Nenegus A.M., Kirschner G., Nunzi M.G., Fiori M.G., Raine C.S. Effects of gangliosides on the expression of autoimmune demyelination in the peripheral nervous system. Ann. Neurol. 30(5):1991;678-685.
19. Shimada K., Koh C.S., Uemura K.I., Yanagisawa N. Suppression of experimental allergic encephalomyelitis in Lewis rats by administration of gangliosides. Cell. Immunol. 154:1994;231-239.
20. Simone I.L., Annunziata P., Maimone D., Liguori M., Leante R., Livrea P. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J. Neurol. Sci. 114(1):1993;49-55.
21. Wekerle H., Kojima K., Lannes-Vieira J., Lassmann H., Linington C. Animal models. Ann. Neurol. 36:1994;S47-S53.
22. Wietholter H., Schabet M., Stevens A., Melms A., Sommer N., Weller M. Influence of gangliosides on experimental allergic neuritis. J. Neuroimmunol. 38(3):1992;221-228.
23. Yokoyama M., Trams E.G., Brady R.O. Sphingolipid antibodies in sera of animals and patients with central nervous system lesions. Proc. Soc. Exp. Biol. Med. 111:1962;350-352.